Veradermics (MANE) Reiterated at Overweight by Cantor Fitzgerald After Investor Dinner
Tweet Send to a Friend
Cantor Fitzgerald analyst Prakhar Agrawal reiterated an Overweight rating on Veradermics (NYSE: MANE).The analyst commented, "We hosted Veradermics' CEO, Reid ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE


